Andreas Daniel Hartkopf
Universität Ulm · 424 works · 36,998 citations · h-index 38
Top works
- PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
- Early dissemination seeds metastasis in breast cancer
- Dose-Response Association of CD8 + Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
- Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer
- Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
- Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer cases
- A Reconsideration of the Rohrschneider Approach for Characterizing Gas Chromatographic Liquid Phases. II. Use of Four Functional Probes
- Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.
- Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status
- Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
- The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
- Endocrine-Resistant Breast Cancer: Mechanisms and Treatment
- Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials
- Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
- Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry
- Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients – Results from a large single-centre analysis
- Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry
- Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients
- The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
- Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature